BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37892277)

  • 1. Uncommon Large and Bilateral Fibrous Cephalic Plaques in a Patient with
    González-Del Angel A; Ruiz-Herrera A; Hernández-Martínez NL; Todd-Quiñones CG; Durán-McKinster C; Herrera-Mora P; Alcántara-Ortigoza MA
    Children (Basel); 2023 Sep; 10(10):. PubMed ID: 37892277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrous cephalic plaques in tuberous sclerosis complex.
    Oyerinde O; Buccine D; Treichel A; Hong C; Lee CR; Moss J; Darling TN
    J Am Acad Dermatol; 2018 Apr; 78(4):717-724. PubMed ID: 29258863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
    Kirk CW; Donnelly DE; Hardy R; Shepherd CW; Morrison PJ
    Ulster Med J; 2020 Jan; 89(1):14-16. PubMed ID: 32218621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex.
    Treichel AM; Pithadia DJ; Lee CR; Oyerinde O; Moss J; Darling TN
    Histopathology; 2021 Oct; 79(4):619-628. PubMed ID: 33882161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
    Cascarino M; Leclerc-Mercier S
    Dermatopathology (Basel); 2021 Jul; 8(3):236-252. PubMed ID: 34287284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care.
    Pounders AJ; Rushing GV; Mahida S; Nonyane BAS; Thomas EA; Tameez RS; Gipson TT
    Ther Adv Rare Dis; 2022; 3():26330040221140125. PubMed ID: 37180419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex.
    Ng SY; Luk HM; Hau EW; Cheng SS; Yu KP; Ho S; Mok MT; Lo IF
    Eur J Med Genet; 2022 Oct; 65(10):104573. PubMed ID: 35918040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, pathological, and molecular correlation of folliculocystic and collagen hamartoma: A new potential diagnostic criterion for tuberous sclerosis complex?
    Apam-Garduño D; Cazarín-Barrientos J; Hernández-Martínez NL; Reyna-Fabián ME; Magaña M; Alcántara-Ortigoza MA; González-Del Angel A; Rivera-Vega MR
    J Cutan Pathol; 2023 Jun; 50(6):481-486. PubMed ID: 36229934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort.
    Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA
    BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatological manifestations of tuberous sclerosis complex (TSC).
    Ebrahimi-Fakhari D; Meyer S; Vogt T; Pföhler C; Müller CSL
    J Dtsch Dermatol Ges; 2017 Jul; 15(7):695-700. PubMed ID: 28598544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
    Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
    Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folliculocystic and Collagen Hamartoma: A Subset of Fibrous Cephalic Plaque.
    Savell AS; Norton K; Heaphy MR
    Cureus; 2021 May; 13(5):e14987. PubMed ID: 34131532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatological and genetic data in tuberous sclerosis: A prospective single-center study of 38 patients.
    Secco LP; Coubes C; Meyer P; Chenine L; Roubertie A; Malinge MC; Bessis D
    Ann Dermatol Venereol; 2022 Dec; 149(4):241-244. PubMed ID: 35527063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel heterozygous TSC2 splicing variant in a patient with Tuberous sclerosis complex: A case report.
    Liu L; Yu C; Yan G
    Medicine (Baltimore); 2022 Jan; 101(3):e28666. PubMed ID: 35060563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous Sclerosis Complex Genotypes and Developmental Phenotype.
    Farach LS; Pearson DA; Woodhouse JP; Schraw JM; Sahin M; Krueger DA; Wu JY; Bebin EM; Lupo PJ; Au KS; Northrup H;
    Pediatr Neurol; 2019 Jul; 96():58-63. PubMed ID: 31005478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of severe tuberous sclerosis complex detected in utero and linked to a novel duplication in the TSC2 gene.
    Mongrain V; van Doesburg NH; Rypens F; Fallet-Bianco C; Maassen J; Dufort-Gervais J; Côté L; Major P
    BMC Neurol; 2020 Sep; 20(1):324. PubMed ID: 32873234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.
    Ekong R; Nellist M; Hoogeveen-Westerveld M; Wentink M; Panzer J; Sparagana S; Emmett W; Dawson NL; Malinge MC; Nabbout R; Carbonara C; Barberis M; Padovan S; Futema M; Plagnol V; Humphries SE; Migone N; Povey S
    Hum Mutat; 2016 Apr; 37(4):364-70. PubMed ID: 26703369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Fan K; Guo Y; Song Z; Yuan L; Zheng W; Hu X; Gong L; Deng H
    Front Mol Neurosci; 2023; 16():1091323. PubMed ID: 37152430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex.
    Okanishi T; Fujimoto A; Enoki H; Ogai M
    Front Med (Lausanne); 2020; 7():1. PubMed ID: 32039222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.